The Company's discovery platform combines rational drug design with radiochemistry to create novel small molecule radioligands that overcome current limitations in radiopharmaceutical development. Its ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention ...

BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures ...

Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

Biotinylated nucleotides have emerged as a powerful tool in molecular biology, enabling researchers to explore genetic materials with unprecedented precision and sensitivity. These modified ...

Carboxylic acids are ubiquitous in bioactive organic molecules and readily available chemical building blocks. Carboxylic ...

Master the art of identifying small molecules through mass spectrometry. Join our course for hands-on training in data ...

The workings of the small intestine have long been a mystery, but now we are discovering the hidden roles this organ plays in appetite, metabolism and the microbiome – and how to look after it better ...

An easy method for efficiently identifying proteins that interact with bioactive molecules has been developed by chemical biologists at RIKEN. This innovation, published in ChemBioChem, could help to ...

Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics. They are ...

Metal-organic frameworks were the next big thing in chemistry when they were invented more than three decades ago. Now, these intriguing materials are becoming commercial tools for capturing carbon ...